Table 2.
Cumulative incidence of COVID-19 diagnosis and incidence of main outcomes in the COVID-19 infected, in the whole study sample and in the age-, sex-, area- and propensity score-matched samples
| All sample % incidence (95% CI) | Matched sample % incidence (95% CI) | |
|---|---|---|
| Incidence of COVID-19 infection | ||
| Non-users | 4.5 (4.4–4.6) | 2.1 (2.0–2.2) |
| ACEi users | 3.7 (3.6–3.8) | 1.7 (1.6–1.8) |
| ARB users | 3.9 (3.8–4.0) | 2.2 (2.0–2.4) |
| COVID-19-infected patients | ||
| Hospitalization | ||
| Non-users | 20.2 (19.1–21.3) | 20.5 (18.7–22.3) |
| ACEi users | 25.2 (22.7–27.7) | 21.9 (19.6–24.2) |
| ARB users | 27.4 (24.3–20.5) | 23.8 (20.7–26.9) |
| Severe episode | ||
| Non-users | 1.9 (1.5–2.3) | 1.9 (1.3–2.5) |
| ACEi users | 3.1 (2.6–3.6) | 2.0 (1.2–2.8) |
| ARB users | 3.4 (2.7–4.1) | 3.0 (1.8–4.2) |
| Death | ||
| Non-users | 7.2 (6.5–7.9) | 6.5 (5.4–7.6) |
| ACEi users | 4.4 (3.8–5.0) | 4.4 (3.3–5.5) |
| ARB users | 5.5 (4.7–6.3) | 7.0 (5.1–8.9) |